Guizhou Bailing Group Pharmaceutical Co. Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Guizhou Bailing Group Pharmaceutical Co. Ltd. - overview
Location
Anshun, -, China
Primary Industry
Pharmaceuticals
About
Based in Anshun, China, Guizhou Bailing Group Pharmaceutical Co. Ltd. manufactures and distributes patented medicines. The company has 5,961 employees.
In 2010, Guizhou Bailing Group Pharmaceutical Co. Ltd. was listed on the Shenzhen Stock Exchange. Anshun Investment acquired a minority stake in the company in 2021.
The company also provides medicine materials. Guizhou Bailing Group Pharmaceutical Co. Ltd. distributes fertilizers, purified water, and the operation of medical institutions.
The company generated CNY 2. 85 billion of revenue in 2019 and CNY 3. 09 billion in 2020, CNY 355. 75 million of EBIT in 2019 and CNY 208.
77 million in 2020, and CNY 282. 75 million of net income in 2019 and CNY 152. 38 million in 2020.
Current Investors
Anshun Investment
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.gzbl.com
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Guizhou Bailing Group Pharmaceutical Co. Ltd. - financials
| Fiscal Year Ended | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Revenue (USD) | 2,214,200,000 | 2,591,800,000 | - | - | - |
| % Revenue Growth (YoY) | - | 17.1% | - | - | - |
| EBITDA (USD) | - | - | - | - | - |
| Operating Income (USD) | 579,900,000 | 632,200,000 | - | - | - |
| Operating Margin | 26.2% | 24.4% | - | - | - |
| % EBITDA Margin | - | - | - | - | - |
| NET Income (USD) | 482,300,000 | 526,100,000 | - | - | - |
| % Net Margin | 21.8% | 20.3% | - | - | - |
Guizhou Bailing Group Pharmaceutical Co. Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Guizhou Bailing Group Pharmaceutical Co. Ltd. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.